Dr Frank F. Craig (CEO, Sphere Fluidics) to speak at PEGS 2017 on May 2nd at 12:50pm. Posted on April 28, 2017 by Frank.Craig Info: http://www.pegsummit.com/Biotherapeutics-Characterization/#Day2
Sphere Fluidics exhibiting at PEGS Summit 2017 in Boston, MA, May 1-5, booth #113. Posted on April 28, 2017 by Frank.Craig Info: www.pegsummit.com
Sphere Fluidics single virus and T-cell project cited as a Case Study by the Cell and Gene Therapy Catapult Posted on April 25, 2017 by Frank.Craig Info: https://ct.catapult.org.uk/case-study/developing-single-cell-integration-assay-quantify-viral-dna-individual-cells
Professors Chris Abell and Wilhem Huck join the Sphere Fluidics’ Scientific Advisory Board. Posted on April 20, 2017 by Frank.Craig Info: http://www.spherefluidics.com/company/scientific-advisory-board/
Sphere Fluidics in Top 10 of IP100 UK 2017 Awards for Patents and in Top 20 in: i) Trade Secrets and ii) Brand and Reputation. Posted on April 18, 2017 by Frank.Craig Info: https://issuu.com/room501/docs/ip100_lr
Sphere Fluidics awarded a European Trademark for Cyto-Surf – its patented solution that enables high quality picodroplet processing on Cyto-Mine®. Posted on April 11, 2017 by Frank.Craig
Sphere Fluidics accepted onto the London Mayor's International Business “Go to Grow” Programme to assist with business scaling. Posted on April 4, 2017 by Frank.Craig
